Boston Trust Walden’s Goldman Sachs ActiveBeta US Large Cap Equity ETF GSLC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,593
Closed -$211K 394
2025
Q4
$211K Sell
1,593
-75
-4% -$9.84K ﹤0.01% 380
2025
Q3
$217K Buy
+1,668
New +$210K ﹤0.01% 384

Other funds holding GSLC

Boston Trust Walden's GSLC Position: Q1 2026 in Review

Boston Trust Walden sold out of Goldman Sachs ActiveBeta US Large Cap Equity ETF (GSLC) in Q1 2026, closing a stake of 1,593 shares — an estimated $211K sold.

Boston Trust Walden first reported a position in GSLC in Q3 2025 and held it in 2 quarters. The position peaked at $217K in Q3 2025. 596 funds tracked by Wall St. Rank hold GSLC as of Q1 2026.

  • Boston Trust Walden reported no remaining Goldman Sachs ActiveBeta US Large Cap Equity ETF position as of Q1 2026 after selling out during the quarter.
  • Boston Trust Walden sold 1,593 Goldman Sachs ActiveBeta US Large Cap Equity ETF shares in Q1 2026, an estimated $211K.
  • Boston Trust Walden first reported a position in Goldman Sachs ActiveBeta US Large Cap Equity ETF in Q3 2025 and held it in 2 quarters.
  • Boston Trust Walden's Goldman Sachs ActiveBeta US Large Cap Equity ETF position peaked at $217K in Q3 2025.
  • 596 funds tracked by Wall St. Rank held Goldman Sachs ActiveBeta US Large Cap Equity ETF as of Q1 2026.

Based on Boston Trust Walden's 13F filing for Q1 2026, filed 24 Apr 2026.